Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Coppertone Sunscreens SPF At Half Of Label Level, Class Action Complaints Allege

Executive Summary

Proposed class action cases filed against Coppertone marketer Bayer and the brand's former owner, Merck & Co., federal and state courts allege two SPF 30 formulas contain half the SPF as advertised. The complaints continue a trend of class actions filed due to sunscreen claims criticized by Consumer Reports.

You may also be interested in...

Consumer Reports Lathers On More Criticism Of Sunscreen SPF Claims

The annual bad marks for sunscreen brands SPF claims from Consumer Reports could be due to CR's nonconformity with FDA-prescribed test guidelines or could signal testing failures or other compliance problems in the industry. In any event, companies retest sunscreen formulas to validate their claims.

Coppertone Heads Off NGO Shade-Throwing With ‘Assurance Assessment’

The Bayer brand commissioned global consulting and standards firm AccountAbility to assess its operations, procedures and testing at the root of Coppertone SPF claims and other labeling aspects. The company now is sharing the results publicly, possibly to get out in front of a conversation that tends to arise this time of year regarding sunscreen safety, effectiveness and truthfulness in marketing.

Oral Care, Topical Product 'Natural' Claims Paint Bullseye For Class Action

Class action complaints alleging misleading "natural" claims for food products have been stayed pending completion of FDA's look at whether it should formally define the term for use in food, but there is no parallel FDA consideration of how the term is used for oral care products and topicals.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts